Polymorphism: an evaluation of the potential risk to the quality of drug products from the Farmácia Popular Rede Própria
2014 ◽
Vol 50
(1)
◽
pp. 1-24
◽
Keyword(s):
Polymorphism in solids is a common phenomenon in drugs, which can lead to compromised quality due to changes in their physicochemical properties, particularly solubility, and, therefore, reduce bioavailability. Herein, a bibliographic survey was performed based on key issues and studies related to polymorphism in active pharmaceutical ingredient (APIs) present in medications from the Farmácia Popular Rede Própria. Polymorphism must be controlled to prevent possible ineffective therapy and/or improper dosage. Few mandatory tests for the identification and control of polymorphism in medications are currently available, which can result in serious public health concerns.
2017 ◽
Vol 37
(1)
◽
pp. 136-161
◽
Keyword(s):
2017 ◽
Vol 117
(3)
◽
pp. 1379-1384
◽
Keyword(s):
2017 ◽
Vol 37
(1)
◽
pp. 212-251
◽
Keyword(s):
2020 ◽
Vol 24
(2)
◽
pp. 323-328
Keyword(s):
2001 ◽
Vol 218
(9)
◽
pp. 1413-1416
◽
2009 ◽
Vol 37
(S1)
◽
pp. 7-8
2018 ◽
Vol 24
(21)
◽
pp. 2456-2472
◽
2019 ◽
Vol 2
(2)
◽
pp. 36-46